Clinical Trials Browser

Interventional × sintilimab × Dermatologic × Clear all

NCT04296786 2020-03-05

Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study

Phase 2 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous